Afatinib in EGFR TKI-naïve patients (pts) with locally advanced/metastatic NSCLC harbouring EGFR mutations: An interim analysis of a phase IIIB trial
Titel:
Afatinib in EGFR TKI-naïve patients (pts) with locally advanced/metastatic NSCLC harbouring EGFR mutations: An interim analysis of a phase IIIB trial
Auteur:
Passaro, A. Laktionov, K.K. Poltoratskiy, A. Egorova, I. Hochmair, M. Migliorino, M.R. Metro, G. Gottfried, M. Tsoi, D. Ostoros, G. Rizzato, S. Mukhametshina, G.Z. Schumacher, M. Novello, S. Dziadziuszko, R. Tang, W. Clementi, L. Cseh, A. Kowalski, D. De Marinis, F.